Browse > Article
http://dx.doi.org/10.4333/KPS.2006.36.5.331

Validated HPLC Method for the Pharmacokinetic Study of Atenolol and Chlorthalidone Combination Therapy in Korean Subjects  

Kang, Hyun-Ah (College of Pharmacy and Institute of Bioequivalence and Bridging Study, Chonnam National University)
Kim, Hwan-Ho (College of Pharmacy and Institute of Bioequivalence and Bridging Study, Chonnam National University)
Kim, Se-Mi (College of Pharmacy and Institute of Bioequivalence and Bridging Study, Chonnam National University)
Yoon, Hwa (College of Pharmacy and Institute of Bioequivalence and Bridging Study, Chonnam National University)
Cho, Hea-Young (General Pharmacology Team, Pharmacological Research Department, NITR, KFDA)
Oh, Seaung-Youl (College of Pharmacy, Sookmyung Women's University)
Choi, Hoo-Kyun (College of Pharmacy, Chosun University)
Lee, Yong-Bok (College of Pharmacy and Institute of Bioequivalence and Bridging Study, Chonnam National University)
Publication Information
Journal of Pharmaceutical Investigation / v.36, no.5, 2006 , pp. 331-338 More about this Journal
Abstract
A rapid, selective and sensitive reverse-phase HPLC methods for the determination of atenolol and chlorthalidone in human serum and whole blood were validated, and applied to the pharmacokinetic study of atenolol and chlorthalidone combination therapy. Atenolol and an internal standard, pindolol, were extracted from human serum by liquid-liquid extraction, and analyzed on a $\mu$-Bondapak C18 $10-{\mu}$ column in a mobile phase of methanol-0.01 M potassium dihydrogenphosphate(30:70, v/v, adjusted to pH 3.5) and fluorescence detection(emission: 300 nm, excitation: 224 nm). Chlorthalidone and an internal standard, probenecid, were extracted form human whole blood by liquid-liquid extraction, and analyzed on a Luna C18 $5-{\mu}$ column in a mobile phase of acetonitrile containing 77% 0.01 M sodium acetate and UV detection at 214 nm. These analysis were performed at three different laboratories using the same quality control(QC) samples. The chromatograms showed good resolution, sensitivity, and no interference by human serum and whole blood, respectively. The methods showed linear responses over a concentration range of 10-1,000 ng/mL for atenolol and 0.05-20 ${\mu}g/mL$ for chlorthalidone, with correlation coefficients of greater than 0.999 at all the three laboratories. Intra- and inter-day assay precision and accuracy fulfilled international requirements. Stability studies(freeze-thaw, short-, long-term, extracted sample and stock solution) showed that atenolol and chlorthalidone were stable. The lower limit of quantitation of atenolol and chlorthalidone were 10 ng/mL and 0.05 ${\mu}g/mL$, respectively, which was sensitive enough for pharmacokinetic studies. These methods were applied to the pharmacokinetic study of atenolol and chlorthalidone in human volunteers following a single oral administration of Hyundai $Tenoretic^{\circledR}$ tablet(atenolol 50 mg and chlorthalidone 12.5 mg) at three different laboratories.
Keywords
Atenolol; Chlorthalidone; Validation; Pharmacokinetics; HPLC;
Citations & Related Records
연도 인용수 순위
  • Reference
1 N.M. Najib, N. Idkaidek, A. Adel, B. Mohammed, S. Al-Masri, I. Admour, S.M. Alam, R. Dham and Qumaruzaman, Comparative Bioavailability of Two Brands of Atenolol 100 mg Tablets (Tensotin and Tenormin) in Healthy Human Volunteers, Biopharm. Drug Dispos., 26, 1-5 (2005)   DOI   ScienceOn
2 K. Parfitt, Martindale-The complete drug reference 32nd ed., Pharmaceutical Press, London, p. 825 (1999)
3 M.J. Rosenberg, K.K. Lam and T.E. Dorsey, Analysis of chlorthalidone in whole blood by high-performance liquid chromatography, J. Chromatogr., 375, 438-443 (1986)   DOI   ScienceOn
4 D.C. Muirhead and R.B. Christie, Simple, sensitive and selective high-performance liquid chromatographic method for analysis of chlorthalidone in whole blood, J. Chromatogr., 416, 420-425 (1987)   DOI
5 $WinNonlin^{TM}$, Users Guide, Ver. 3.0, Pharsight Corp., Mountain View, CA, USA, 1998-1999
6 H.Y. Cho, H.A. Kang, S. Lee, S.H. Baek, Y.B. Lee, Bio- equivalence of Samchundang Atenolol Tablet to Tenolmin Tablet, Yakhak Hoeji, 47(5), 339-344 (2003)
7 J. McAinsh, B.H. Holmes, T.J. Fitzsimons and J. Young, Bioavailability in man of atenolol and chlorthalidone from a combination formulation, Biopharm. Drug Dispos., 7(3), 223-231 (1986)   DOI   ScienceOn
8 F.S. Leite, V.A. Pereira, C.E. Omosako, M.J. Carmona, J.J. Auler and S.R. Santos, A micromethod for the quantification of atenolol in plasma using high-performance liquid chroma- tography with fluorescence detection: Therapeutic drug monitoring of two patients with severe coronary insufficiency before cardiac surgery, Ther. Drug Monit., 28(2), 237-244 (2006)   DOI   ScienceOn
9 P. Modamio, C.F. Lastra and E.L. Marino, Error structure for the HPLC analysis for atenolol, metoprolol and propranolol: a useful weighting method in parameter estimation, J. Pharm. Biomed. Anal., 17(3), 507-513 (1998)   DOI   ScienceOn
10 C. Giachetti, A. Tenconi, S. Canali and G. Zanolo, Simul- taneous determination of atenolol and chlorthalidone in plasma by high-performance liquid chromatography Application to pharmacokinetic studies in man, J. Chromatogr. B, 698, 187-194 (1997)   DOI   ScienceOn
11 A. Marzo, N.C. Monti, B.L. Dal, P. Mazzucchelli, F. Crivelli, R.A. Tettamanti, S. Ismaili, M.R. Uhr, C. Ronchi and E. Porziotta, Comparative bioavilability of two formulations containing atenolol and chlortalidone associated in a 4:1 fixed combination, Atzneimittelforschung, 50(9), 802-808 (2000)
12 A.P. Argekar and S.G. Powar, Simultaneous determination of atenolol and amlodipine in tablets by high-performance thin-layer chromatography, J. Pharm. Biomed. Anal., 21, 1137-1142 (2000)   DOI   ScienceOn
13 J. McAinsh, W. Bastain, J. Toung and J.D. Harry, Bioavail- ability in man of atenolol and chlorthalidone from a combination formulation, Biopharm. Drug Dispos., 2(2), 147-156 (1981)   DOI   ScienceOn
14 A. Wolf-Coporda, F. Plavsic and B. Vrhovac, Determination of biological equivalence of two atenolol preparation, Int. J. Clin. Pharmacol. Ther. Toxicol., 25(10), 567-571 (1987)
15 Korea Food & Drug Administration Notification No. 200260, Standard Protocol of Bioequivalence Test (2002. 11. 22)
16 R.D. Johnson and R.J. Lewis, Quantitation of atenolol, metoprolol, and propranolol in postmortem human fluid and tissue specimens via LC/APCI-MS, Forensic Sci. Int., 156(2-3), 106-117 (2006)   DOI   ScienceOn